1. Home
  2. BYSI vs PGZ Comparison

BYSI vs PGZ Comparison

Compare BYSI & PGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$1.13

Market Cap

58.4M

Sector

Health Care

ML Signal

N/A

Logo Principal Real Estate Income Fund of Beneficial Interest

PGZ

Principal Real Estate Income Fund of Beneficial Interest

HOLD

Current Price

$10.24

Market Cap

68.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYSI
PGZ
Founded
2010
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
58.4M
68.5M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
BYSI
PGZ
Price
$1.13
$10.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.7K
18.9K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
12.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.16
$9.32
52 Week High
$2.44
$10.64

Technical Indicators

Market Signals
Indicator
BYSI
PGZ
Relative Strength Index (RSI) 26.58 51.95
Support Level N/A $10.19
Resistance Level $1.60 $10.55
Average True Range (ATR) 0.13 0.09
MACD -0.04 -0.02
Stochastic Oscillator 1.91 15.93

Price Performance

Historical Comparison
BYSI
PGZ

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

About PGZ Principal Real Estate Income Fund of Beneficial Interest

Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Singapore, South Korea, British Virgin Islands and more.

Share on Social Networks: